Amphastar Pharmaceuticals, Inc. (AMPH)
26.22
+0.26
(+1.02%)
USD |
NASDAQ |
Jan 21, 16:00
26.22
0.00 (0.00%)
After-Hours: 20:00
Amphastar Pharmaceuticals Enterprise Value: 1.571B for Jan. 20, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Eli Lilly & Co. | 964.62B |
| Pfizer Inc. | 192.12B |
| Supernus Pharmaceuticals, Inc. | 2.618B |
| Catalyst Pharmaceuticals, Inc. | 2.187B |
| CorMedix, Inc. | 490.74M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 17.35M |
| Revenue (Quarterly) | 191.84M |
| Total Expenses (Quarterly) | 174.49M |
| EPS Diluted (Quarterly) | 0.3639 |
| Gross Profit Margin (Quarterly) | 49.53% |
| Profit Margin (Quarterly) | 9.04% |
| Earnings Yield | 8.60% |
| Operating Earnings Yield | 11.61% |
| Normalized Earnings Yield | 8.510 |